Chlorothiazide Sodium (American Regent, Inc.)


Welcome to the PulseAid listing for the Chlorothiazide Sodium drug offered from American Regent, Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Chlorothiazide Sodium
SUBSTANCE NAME: CHLOROTHIAZIDE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00


Chlorothiazide Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChlorothiazide Sodium from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/18mL)
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-1820_614c7c90-6d95-436f-ac98-0281f03f01ff
PRODUCT NDC: 0517-1820
APPLICATION NUMBER: ANDA202561

Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Chlorothiazide Sodium
American Regent, Inc.Chlorothiazide Sodium
Fresenius Kabi USA, LLCChlorothiazide
Mylan Institutional LLCchlorothiazide sodium
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)Sodium Diuril
Sagent Pharmaceuticalschlorothiazide sodium